These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6503334)

  • 21. Primary prevention of neural tube defects with folate in Western Australia: the value of the Western Australian Birth Defects Registry.
    Bower C
    Congenit Anom (Kyoto); 2006 Jun; 46(2):118-21. PubMed ID: 16732771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neural tube defects (NTD)--assessment from the perspective of 25 years of studies].
    Pietrzyk JJ
    Przegl Lek; 1998; 55(4):164-7. PubMed ID: 9656740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetic counseling in neural tube defects; a follow-up study].
    Veenema H; Ouboter-Kooij EC; van Holthe tot Echten JE
    Ned Tijdschr Geneeskd; 1981 Sep; 125(37):1492-6. PubMed ID: 7290222
    [No Abstract]   [Full Text] [Related]  

  • 24. Does periconceptional multivitamin use reduce the risk of neural tube defects associated with other birth defects? data from two population-based case-control studies.
    Khoury MJ; Shaw GM; Moore CA; Lammer EJ; Mulinare J
    Am J Med Genet; 1996 Jan; 61(1):30-6. PubMed ID: 8741914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Folic acid deficiency and its association with neural tube defects in northern Mexico].
    Rodríguez-Morán M; Guerrero-Romero JF; Parra-Quezada M; Segura-Pineda MJ; Levario-Carrillo M; Sotelo-Ham EI
    Salud Publica Mex; 1998; 40(6):474-80. PubMed ID: 9927882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The recurrence risk for neural tube defects in the United States: a collaborative study.
    Cowchock S; Ainbender E; Prescott G; Crandall B; Lau L; Heller R; Muir WA; Kloza E; Feigelson M; Mennuti M; Cederquist L
    Am J Med Genet; 1980; 5(3):309-14. PubMed ID: 7405962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Syndromes with neural tube defects: epidemiologic analysis in Spain].
    Martínez-Frías ML; Félix Rodríguez V; Hernández Ramón F; Martín Bermejo M; López Soler JA; Ayala Garcés A; Bermejo Sánchez E; Rodríguez Pinilla E
    An Esp Pediatr; 1996 Sep; 45(3):276-80. PubMed ID: 9019969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mini-review: toward understanding mechanisms of genetic neural tube defects in mice.
    Harris MJ; Juriloff DM
    Teratology; 1999 Nov; 60(5):292-305. PubMed ID: 10525207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neural tube defects: are neurulation and canalization forms causally distinct?
    Seller MJ
    Am J Med Genet; 1990 Mar; 35(3):394-6. PubMed ID: 2309788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced folate carrier polymorphism (80A-->G) and neural tube defects.
    De Marco P; Calevo MG; Moroni A; Merello E; Raso A; Finnell RH; Zhu H; Andreussi L; Cama A; Capra V
    Eur J Hum Genet; 2003 Mar; 11(3):245-52. PubMed ID: 12673279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population.
    De Marco P; Calevo MG; Moroni A; Arata L; Merello E; Finnell RH; Zhu H; Andreussi L; Cama A; Capra V
    J Hum Genet; 2002; 47(6):319-24. PubMed ID: 12111380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of genetic mutation in familial Hirschsprung's disease in South Africa: towards genetic counseling.
    Moore SW; Zaahl MG
    J Pediatr Surg; 2008 Feb; 43(2):325-9. PubMed ID: 18280283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas hispanic population.
    Barber R; Shalat S; Hendricks K; Joggerst B; Larsen R; Suarez L; Finnell R
    Mol Genet Metab; 2000 May; 70(1):45-52. PubMed ID: 10833330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population.
    Richter B; Stegmann K; Röper B; Böddeker I; Ngo ET; Koch MC
    J Hum Genet; 2001; 46(3):105-9. PubMed ID: 11310576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Karyotyping for isolated neural tube defects. A report of two cases.
    O'Reilly GC; Shields LE
    J Reprod Med; 2000 Nov; 45(11):950-2. PubMed ID: 11127112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology, prevention, and potential treatment of neural tube defects.
    Manning SM; Jennings R; Madsen JR
    Ment Retard Dev Disabil Res Rev; 2000; 6(1):6-14. PubMed ID: 10899792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional patterns of mothers of children with neural tube defects in Newfoundland.
    Friel JK; Frecker M; Fraser FC
    Am J Med Genet; 1995 Jan; 55(2):195-9. PubMed ID: 7717417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic evaluation of a neural tube defect recurrence-prevention program.
    Grosse SD; Ouyang L; Collins JS; Green D; Dean JH; Stevenson RE
    Am J Prev Med; 2008 Dec; 35(6):572-7. PubMed ID: 18845415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are the recommendations on the prevention of neural tube defects working?
    Stoll C; Alembik Y; Dott B
    Eur J Med Genet; 2006; 49(6):461-5. PubMed ID: 16877057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cultural influences and neural tube defects in the East Indian Sikh population of British Columbia.
    Keena BA; Jawanda M; Hall JG
    Birth Defects Orig Artic Ser; 1987; 23(6):245-8. PubMed ID: 3435767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.